Category: Alzheimer's Disease
Alzheimer's Disease market research reports by The Business Research Company
-
Alzheimer's Drugs Global Market Report 2025
Alzheimer's Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on alzheimer's drugs market which is experiencing strong growth. The report gives a g ... Read More
-
Medical Foods Global Market Report 2025 Including: 1) By Type: Pills; Powder 2) By Application: Alzheimer's Disease; Diabetic Neuropathy; Nutritional Deficiency; ADHD 3) By Sales Channel: Retail Sales; Online Sales; Institutional Sales Covering: Nestlé SA; Danone SA; Fresenius Kabi AG; Mead Johnson & Company LLC; Primus Pharmaceuticals Inc.
Medical Foods Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on medical foods market which is experiencing strong growth. The report gives a guide to ... Read More
-
Alzheimer’s Disease Treatment Global Market Report 2024
Alzheimer’s Disease Treatment Global Market Report 2024 Including: 1) By Drug Class: Cholinergic; Memantine; Combined Drug; AChE inhibitors; Immunoglobulins 2) By Drug Type: Cholinesterase Inhibitors; NMDA Receptor Antagonists 3) By Therapeutics: Cholinesterase Inhibitors; NMDA Receptor AntagonistsC ... Read More
-
Glycomic Therapeutics Global Market Report 2023 Including: 1) By Class: Isolated; Synthetic 2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids 3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons 4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gaucher’s Disease; Mps-1 And IV; Cancer; Alzheimer’s Disease; Influenza Type A And B Covering: F Hoffmann-La Roche Ltd.; Bayer AG; Sanofi SA; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc
Glycomic Therapeutics Global Market Report 2023 Including: 1) By Class: Isolated; Synthetic2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids ... Read More
Research Assistance
